Skip to content
Use caution Drug recall · FDA · Published September 29, 2026

Teva Recalls Metoclopramide Tablets Due to Foreign Contaminants

Teva Pharmaceuticals recalls specific lots of 5 mg Metoclopramide tablets due to the presence of foreign tablets and capsules. Check your bottle's lot number.

🇺🇸 FDA recall #D-0038-2027DrugTeva Pharmaceuticals ›
✎ GovInfoNow plain-language explainer

Teva Pharmaceuticals is recalling specific lots of Metoclopramide Tablets, USP, 5 mg because they may contain foreign tablets or capsules. This contamination poses a risk of unintended medication intake. The recall covers products distributed nationwide in the United States. Read more at govinfonow.com/recall/1756679-teva-pharmaceuticals-usa-inc-recalls-metoclopramide-tablets-usp-5-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/1756679-teva-pharmaceuticals-usa-inc-recalls-metoclopramide-tablets-usp-5-mg · Published October 27, 2026 · Updated October 27, 2026 · FDA enforcement record: FDA #D-0038-2027

Cite this page

“Teva Recalls Metoclopramide Tablets Due to Foreign Contaminants.” GovInfoNow, updated October 27, 2026. https://govinfonow.com/recall/1756679-teva-pharmaceuticals-usa-inc-recalls-metoclopramide-tablets-usp-5-mg. Based on FDA recall #D-0038-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0038-2027%22&limit=1).

The FDA announced on Sept. 29, 2026, that Teva Pharmaceuticals USA, Inc. is recalling Metoclopramide Tablets, USP, 5 mg due to the presence of foreign tablets or capsules. The recall affects 240,448 cartons distributed nationwide. Owners should stop using the product immediately.

How to tell if you have it

  • Brand: Teva Pharmaceuticals
  • Product: Metoclopramide Tablets, USP, 5 mg
  • Packaging: 100 or 500 tablets per bottle
  • NDC 100 Tablets: 0093-2204-01
  • NDC 500 Tablets: 0093-2204-05
  • Lot numbers (100 Tablets): 8634085, 8635085, 8636085
  • Lot number (500 Tablets): 8633085
  • Expiration date: 07/2027
  • Distribution: US Nationwide

The hazard

The recall is due to the presence of foreign tablets or capsules in the Metoclopramide bottles. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Teva Pharmaceuticals USA, Inc. has 60 other recalls on record since April 2, 2012. Other recent recalls of similar products include Teva recalling traZODone 50mg tablets with foreign tablets risk (Aug. 24, 2026) and American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence (Oct. 6, 2026).

How to tell if you have this one

Check your bottle for Metoclopramide Tablets, USP, 5 mg manufactured by Teva Pharmaceuticals. Look for NDC numbers 0093-2204-01 (100 tablets) or 0093-2204-05 (500 tablets). Verify the lot number and expiry date against the recalled lots: 8634085, 8635085, 8636085, or 8633085, all expiring in 07/2027.

  • Brand
    Teva Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your Metoclopramide tablets match the recalled NDC numbers and lot numbers listed in the record.

  2. Contact Your Pharmacist

    If you have a recalled bottle, contact your pharmacy or healthcare provider immediately for instructions on return or replacement.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 22 days after the firm started it.

1. Firm started the recall: Sep 29, 202612. FDA classified it Class II: Oct 13, 202623. Published in FDA’s Enforcement Report: Oct 21, 202634. Added to GovInfoNow: Oct 27, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Teva Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0038-2027 (September 29, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0038-2027 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 27, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA